Charlotte Ameloot
Charlotte Ameloot has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Alan Fauconnier
Culture In Vivo ASBL, Nivelles, Belgium
1 shared publication - Daniel De Vos
Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, Bruynstraat 1, 1120 Brussel, Belgium
1 shared publication - Gilbert Verbeken
Laboratory for Molecular and Cellular Technology, Queen Astrid Military Hospital, 1120 Brussels, Belgium
1 shared publication - Isabelle Huys
Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, O&N2, Herestraat 49, Box 521, 3000 Leuven, Belgium
1 shared publication - Jean-Paul Pirnay
ESGNTA - ESCMID study group for non-traditional antibacterials, Basel, Switzerland
1 shared publication - Pieter-Jan Ceyssens
Bacterial Diseases, Unit Antibiotic Resistance, Scientific Institute of Public Health, Rue Engelandstraat 642, 1180 Brussel, Belgium
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
The Magistral Phage
Since time immemorial, phages—the viral parasites of bacteria—have been protecting Earth’s biosphere against bacterial overgrowth. Today, phages could help address the antibiotic resistance crisis that affects all of society. The greatest hurdle to the introduction of phage therapy in Western medicine is the lack of an appropriate legal and regulatory framework. Belgium is now implementing a pragmatic phage therapy framework that centers on the magistral preparation (compounding pharmacy in the US) of tailor-made phage medicines.
Top Cited PapersOpen AccessThe Magistral Phage
Since time immemorial, phages—the viral parasites of bacteria—have been protecting Earth’s biosphere against bacterial overgrowth. Today, phages could help address the antibiotic resistance crisis that affects all of society. The greatest hurdle to the introduction of phage therapy in Western medicine is the lack of an appropriate legal and regulatory framework. Belgium is now implementing a pragmatic phage therapy framework that centers on the magistral preparation (compounding pharmacy in the US) of tailor-made phage medicines.